Predicting Risk of RRT in Patients with CKD.
作者信息
Grams Morgan E, Coresh Josef
机构信息
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland; and.
Departments of Epidemiology and.
出版信息
Clin J Am Soc Nephrol. 2017 Jan 6;12(1):3-4. doi: 10.2215/CJN.11841116. Epub 2016 Dec 27.
Abstract
摘要
相似文献
1
Predicting Risk of RRT in Patients with CKD.预测慢性肾脏病患者接受肾脏替代治疗的风险。
Clin J Am Soc Nephrol. 2017 Jan 6;12(1):3-4. doi: 10.2215/CJN.11841116. Epub 2016 Dec 27.
2
Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).尿中性粒细胞明胶酶相关载脂蛋白可能有助于预测非蛋白尿 3 期和 4 期慢性肾脏病（CKD）患者的肾脏下降。
Nephrol Dial Transplant. 2013 Jun;28(6):1569-79. doi: 10.1093/ndt/gfs586. Epub 2013 Jan 16.
3
Low renal replacement therapy incidence among slowly progressing elderly chronic kidney disease patients referred to nephrology care: an observational study.转诊至肾脏病科的进展缓慢的老年慢性肾脏病患者肾替代治疗发生率较低：一项观察性研究。
BMC Nephrol. 2017 Feb 10;18(1):59. doi: 10.1186/s12882-017-0473-1.
4
Serum Creatinine and Chronic Kidney Disease-Epidemiology Estimated Glomerular Filtration Rate: Independent Predictors of Renal Replacement Therapy following Cardiac Surgery.血清肌酐和慢性肾脏病-估算肾小球滤过率的流行病学：心脏手术后肾脏替代治疗的独立预测因素。
Am J Nephrol. 2018;48(2):108-117. doi: 10.1159/000492182. Epub 2018 Aug 15.
5
Chronic kidney disease progression to end stage renal disease: a single center experience of the role of the underlying kidney disease.慢性肾脏病进展至终末期肾病：关于潜在肾脏疾病作用的单中心经验
Ther Apher Dial. 2013 Aug;17(4):363-7. doi: 10.1111/1744-9987.12079.
6
Timing of renal replacement therapy and long-term risk of chronic kidney disease and death in intensive care patients with acute kidney injury.重症监护病房急性肾损伤患者肾脏替代治疗时机与慢性肾脏病和死亡的长期风险。
Crit Care. 2017 Dec 28;21(1):326. doi: 10.1186/s13054-017-1903-y.
7
Predicting 5-Year Risk of RRT in Stage 3 or 4 CKD: Development and External Validation.预测 3 或 4 期 CKD 患者的 RRT 5 年风险：开发与外部验证。
Clin J Am Soc Nephrol. 2017 Jan 6;12(1):87-94. doi: 10.2215/CJN.01290216. Epub 2016 Dec 27.
8
Cancer patterns and association with mortality and renal outcomes in non-dialysis dependent chronic kidney disease: a matched cohort study.非透析依赖型慢性肾脏病患者的癌症发病模式及与死亡率和肾脏结局的关系：一项匹配队列研究。
BMC Nephrol. 2019 Oct 22;20(1):380. doi: 10.1186/s12882-019-1578-5.
9
Timing of patient-reported renal replacement therapy planning discussions by disease severity among children and young adults with chronic kidney disease.慢性肾脏病儿童和青年患者按疾病严重程度进行患者报告的肾脏替代治疗规划讨论的时机。
Pediatr Nephrol. 2020 Oct;35(10):1925-1933. doi: 10.1007/s00467-020-04542-2. Epub 2020 May 3.
10
Definitions of progression in chronic kidney disease--predictors and relationship to renal replacement therapy in a population cohort with a 6 year follow-up.慢性肾脏病进展的定义——在一个进行了6年随访的人群队列中的预测因素及其与肾脏替代治疗的关系
Nephrol Dial Transplant. 2014 Feb;29(2):333-41. doi: 10.1093/ndt/gft393. Epub 2013 Sep 29.
引用本文的文献
1
Predictive Value of Kidney Failure Risk Equation and Neutrophil Gelatinase-Associated Lipocalin for Chronic Kidney Disease Progression in Chinese Population - A Retrospective Study.肾衰竭风险方程和中性粒细胞明胶酶相关脂质运载蛋白对中国人群慢性肾脏病进展的预测价值——一项回顾性研究
Int J Gen Med. 2024 Dec 30;17:6557-6565. doi: 10.2147/IJGM.S497268. eCollection 2024.
2
External Validation of the Kidney Failure Risk Equation Among Urban Community-Based Chinese Patients With CKD.中国城市社区慢性肾脏病患者肾衰竭风险方程的外部验证
Kidney Med. 2024 Mar 26;6(5):100817. doi: 10.1016/j.xkme.2024.100817. eCollection 2024 May.
3
Risk Prediction and Management of Chronic Kidney Disease in People Living with Type 2 Diabetes Mellitus.2 型糖尿病患者慢性肾脏病的风险预测和管理。
Diabetes Metab J. 2024 Mar;48(2):196-207. doi: 10.4093/dmj.2023.0244. Epub 2024 Jan 26.
4
Referral patterns, disease progression and impact of the kidney failure risk equation (KFRE) in a Queensland Chronic Kidney Disease Registry (CKD.QLD) cohort: a study protocol.昆士兰慢性肾脏病登记处（CKD.QLD）队列中转诊模式、疾病进展及肾衰竭风险方程（KFRE）的影响：研究方案。
BMJ Open. 2022 Feb 22;12(2):e052790. doi: 10.1136/bmjopen-2021-052790.
5
A validation study of the kidney failure risk equation in advanced chronic kidney disease according to disease aetiology with evaluation of discrimination, calibration and clinical utility.根据病因对晚期慢性肾脏病的肾衰竭风险方程进行验证研究，评估其区分度、校准度和临床实用性。
BMC Nephrol. 2021 May 24;22(1):194. doi: 10.1186/s12882-021-02402-1.
6
Cross-sectional observation study to investigate the impact of risk-based stratification on care pathways for patients with chronic kidney disease: protocol paper.横断面观察研究，旨在探讨基于风险分层对慢性肾脏病患者护理路径的影响：研究方案。
BMJ Open. 2019 Jun 9;9(6):e027315. doi: 10.1136/bmjopen-2018-027315.
7
Temporal validation of the CT-PIRP prognostic model for mortality and renal replacement therapy initiation in chronic kidney disease patients.慢性肾脏病患者死亡率及开始肾脏替代治疗的CT-PIRP预后模型的时间验证
BMC Nephrol. 2019 May 17;20(1):177. doi: 10.1186/s12882-019-1345-7.
8
Risks of Adverse Events in Advanced CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.晚期慢性肾脏病不良事件的风险：慢性肾功能不全队列（CRIC）研究
Am J Kidney Dis. 2017 Sep;70(3):337-346. doi: 10.1053/j.ajkd.2017.01.050. Epub 2017 Mar 30.
Zotero 插件